Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome

Journal of the American Society of Nephrology

Volumn 9, Issue 2, 1998, Pages 243-251

  Drukker, Alfred ^a   Eddy, Allison A ^b,c   Mcculloch, Lori ^b   Liu, Elaine ^b  

^a HEBREW UNIVERSITY   (Israel)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; CHOLESTEROL; COLLAGEN; FIBRONECTIN; LIPID; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MESSENGER RNA; MEVINOLIN; PROBUCOL; PROCOLLAGEN; PROTEIN; PROTEINASE INHIBITOR; PUROMYCIN AMINONUCLEOSIDE; RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE; IMMUNOFLUORESCENCE; KIDNEY INTERSTITIUM; LIPID PEROXIDATION; NEPHROTIC SYNDROME; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT FAILURE;

EID: 0031952094     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Keane WF: Lipids and the kidney. Kidney Int 46: 910-920, 1994
2. Diamond JR: Effect of lipid abnormalities on the progression of renal damage: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 39[Suppl 31]: S29-S34, 1991
3. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF, Phillips F: Effects of reduced renal mass on tissue lipids and renal injury in hyperlipidemic rats. Kidney Int 35: 40-47, 1989
4. Kasiske BL, O'Donnell MP, Schmitz PG, Kim Y, Keane WF: Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 37: 880-891, 1990
5. Magil AB: Tubulointerstitial lesions in young Zucker rats. Am J Kidney Dis 25: 478-485, 1995
6. Peric-Golia L, Peric-Golia M: Aortic and renal lesions in hypercholesterolemic adult, male, virgin Sprague-Dawley rats. Atherosclerosis 46: 57-65, 1983
7. Wellmann KF, Volk BW: Renal changes in experimental hypercholesterolemia in normal and in subdiabetic rabbits. II. Long-term studies. Lab Invest 24: 144-155, 1971
8. Trachtman H, Schwob N, Maesaka J, Valderrama E: Dietary vitamin E supplementation ameliorates renal injury in chronic puromycin aminonucleoside nephropathy. J Am Soc Nephrol 5: 1811-1819, 1995
9. Lee HS, Jeong JY, Kim BC, Kim YS, Zhang YZ, Chung HK: Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis. Kidney Int 51: 1151-1159, 1997
10. Magil A: Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant. J Am Soc Nephrol 7: 2340-2347, 1996
11. Eddy AA, Michael AF: Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis. Kidney Int 33: 14-23, 1988
12. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA: Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Am J Pathol 141: 1381-1396, 1992
13. Quinn MT, Parthasarathy S, Fong LG, Steinberg D: Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 84: 2995-2998, 1987
14. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D: Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88: 5252-5256, 1991
15. Eddy AA: Interstitial macrophages as mediators of renal fibrosis. Exp Nephrol 3: 76-79, 1995
16. Ding G, van Goor H, Ricardo SD, Orlowski JM, Diamond JR: Oxidized LDL stimulates the expression of TGF-β and fibronectin in human glomerular epithelial cells. Kidney Int 51: 147-154, 1997
17. Lee HS, Kim BC, Kim YS, Choi KH, Chung HK: Involvement of oxidation in LDL-induced collagen gene regulation in mesangial cells. Kidney Int 50: 1582-1590, 1996
18. Glasser RJ, Velosa JA, Michael AF: Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis. Lab Invest 36: 519-526, 1977
19. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA: The pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. Kidney Int 40: 1020-1031, 1991
20. Eddy A: Protein restriction reduces transforming growth factor-β and interstitial fibrosis in nephrotic syndrome. Am J Physiol 266: F884-F893, 1994
21. Kivirikko KI, Laitinen O, Prockop DJ: Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 19: 249-255, 1967
22. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358, 1979
23. Dijkstra CD, Döpp EA, Joling P, Kraal G: The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54: 589-599, 1985
24. Balza E, Borsi L, Allemanni G, Zardi L: Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett 228: 42-44, 1988
25. Chirgwin JM, Przybyla AE, MacDonald RJ. Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979
26. Nakatsukasa H, Nagy P, Evarts RP, Hsia C-C, Marsden E, Thorgeirsson SS: Cellular distribution of transforming growth factor-β1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 85: 1833-1843, 1990
27. Toman PD, de Crombrugghe B: The mouse type-III procollagenencoding gene: Genomic cloning and complete DNA sequence. Gene (Amst) 147: 161-168, 1994
28. Schwarzbauer JE, Tamkun JW, Lemischka IR, Hynes RO: Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell 35: 421-431, 1983
29. Khokha R, Denhardt DT: On the use of anti-sense RNA: Down-regulation of mRNA encoding a metalloproteinase inhibitor. Anticancer Res 7: 653-660, 1987
30. Zehab R, Gelehrter TD: Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1. Gene (Amst) 73: 459-468, 1988
31. Qian SW, Kondaiah P, Roberts AB, Sporn MB: cDNA cloning by PCR of rat transforming growth factor β-1. Nucleic Acids Res 18: 3059, 1990
32. Chien KR: Genes and physiology: Molecular physiology in genetically engineered animals. J Clin Invest 97: 901-909, 1996
33. Breslow JL: Transgenic mouse models of lipoprotein metabolism and atherosclerosis. Proc Natl Acad Sci USA 90: 8314-8318, 1993
34. Helmchen U, Wenzel UO: Benign and malignant nephrosclerosis and renovascular disease. In: Renal Pathology with Clinical and Functional Correlations, edited by Tisher CC, Brenner BM, Philadelphia, J. B. Lippincott, 1994, pp 1201-1238
35. Reichenberg Y, Pomeranz A, Schurr D, Levy E, Stankiewicz H, Elath U, Rosenmann E, Drukker A: Dietary-induced hyperlipidemia and renal function in the uremic rat. Child Nephrol Urol 11: 1-5, 1991
36. Yoshioka T, Bills T, Moore-Jarrett T, Greene HL, Burr IM, Ichikawa I: Role of intrinsic antioxidant enzymes in renal oxidant injury. Kidney Int 38: 282-288, 1990
37. Diamond JR, Bonventre JV, Karnovsky MJ: A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int 29: 478-483, 1986
38. Thakur V, Walker PD, Shah SV: Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced protein-uria. Kidney Int 34: 494-499, 1988
39. Ricardo SD, Bertram JF, Ryan GB: Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats. J Am Soc Nephrol 4: 1974-1986, 1994
40. Lehr H-A, Kröber M, Hübner C, Vajkoczy P, Menger MD, Nolte D, Kohlschütter A, Messmer K: Stimulation of leukocyte/endothelium interaction by oxidized low-density lipoprotein in hairless mice: Involvement of CD11b/CD18 adhesion receptor complex. Lab Invest 68: 388-395, 1993
41. Kume N, Cybulsky MI, Gimbrone MAJ: Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90: 1138-1144, 1992
42. Khan BV, Parthasarathy SS, Alexander RW, Medford RM: Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 95: 1262-1270, 1995
43. Eddy AA, Warren JS: Expression and function of monocyte chemoattractant protein-1 in experimental nephrotic syndrome. Clin Immunol Immunopathol 78: 140-151, 1996
44. Eddy AA: Expression of genes that promote renal interstitial fibrosis in rats with proteinuria. Kidney Int 49[Suppl 54]: S49-S54, 1996
45. Eddy AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 5: 1273-1287, 1994
46. Eddy AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7: 2495-2508, 1996
47. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ: Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature (Lond) 344: 254-257, 1990
48. Witztum JL, Steinberg D: Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88: 1785-1792, 1991
49. Simionescu M, Simionescu N: Proatherosclerotic events: Pathobiochemical changes occurring in the arterial wall before monocyte migration. FASEB J 7: 1359-1366, 1993
50. Oberley TD, Sempf JM, Oberley LW: Immunohistochemical localization of antioxidant enzymes during hamster kidney development. Histochem J 27: 575-586, 1995
51. White CR, Brock TA, Chang L-Y, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA, Tarpey MM: Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA 91: 1044-1048, 1994
52. Ong ACM, Moorhead JF: Tubular lipidosis: Epiphenomenon or pathogenetic lesion in human renal disease? Kidney Int 45: 753-762, 1994
53. Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Hayakawa I, Kanamori H, Aburatani H, Takaku F, Suzuki H, Kobari Y, Miyal T, Takahashi K, Cohen EH, Wydro R, Housman DE, Kodama T: Human macrophage scavenger receptors: Primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci USA 87: 9133-9137, 1990
54. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M: Type 1 macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature (Lond) 343: 531-535, 1990
55. Schönholzer KW, Waldron M, Magil AB: Intraglomerular foam cells and human focal glomerulosclerosis. Nephron 62: 130-136, 1992
56. Regnström J, Nilsson J: Lipid oxidation and inflammation-induced intimai fibrosis in coronary heart disease. J Lab Clin Med 124: 162-168, 1994
57. Agarwal A, Balla J, Croatt A, Nath K: Oxidized LDL injures renal tubular epithelial cells: Implications for tubulointerstitial disease [Abstract]. J Am Soc Nephrol 5: 935, 1994
58. Freeman M, Ashkenas J, Rees DJG, Kingsley DM, Copeland NG, Jenkins NA, Krieger M: An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc Natl Acad Sci USA 87: 8810-8814, 1990
59. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271: 518-520, 1996
60. Holness CL, da Silva RP, Fawcell J, Gordon S, Simmons D: Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/Igp family. J Biol Chem 268: 9661-9666, 1993
61. Elomaa O, Kangas M, Sahlberg C, Tuukkanen J, Sormunen R, Liakka A, Thesleff I, Kraal G, Tryggvason K: Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 80: 603-609, 1995
62. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268: 11811-11816, 1993
63. Stanton LW, White RT, Bryant CM, Protter AA, Endemann G: A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J Biol Chem 267: 22446-22451, 1992
64. Eddy AA: Interstitial nephritis induced by heterologous protein-overload proteinuria. Am J Pathol 135: 719-733, 1989
65. Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature of renal disease progression. Kidney Int 51: 2-15, 1997
66. Burton C, Harris KPG: The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 27: 765-775, 1996
67. Perna A, Remuzzi G: Abnormal permeability to proteins and glomerular lesions: A meta-analysis of experimental and human studies. Am J Kidney Dis 27: 34-41, 1996